RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Middle Aged

Back to Details
This is a "connection" page, showing publications Luis M. Vilá has written about Middle Aged.
Luis M. Vilá
Connection Strength
1.764
Middle Aged
  1. Serrano-Arroyo L, Gonz?lez-Mel?ndez A, R?os-Rivera R, Rodr?guez-Gonz?lez V, Vil? LM. Impact of SARS-CoV-2 pre-delta/delta and omicron variants on clinical outcomes in a systemic lupus erythematosus cohort from Puerto Rico. Lupus. 2025 Apr; 34(4):415-424.
    View in: PubMed
    Score: 0.079
  2. ?lvarez P?rez LF, Gonz?lez-Mel?ndez A, Vil? LM. Severe gingival inflammation and bleeding as the sole manifestation of granulomatosis with polyangiitis. BMJ Case Rep. 2024 Aug 22; 17(8).
    View in: PubMed
    Score: 0.077
  3. Santiago A, Crespo-Ramos SM, Correa-Rivas M, Vil? LM. Monarticular rheumatoid arthritis of the elbow. BMJ Case Rep. 2022 Mar 07; 15(3).
    View in: PubMed
    Score: 0.065
  4. Medina-Cintr?n N, Mart?nez I, P?rez-R?os N, Berr?os-L?pez Y, Vil? LM. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis. Am J Trop Med Hyg. 2021 03 08; 104(5):1741-1746.
    View in: PubMed
    Score: 0.060
  5. Jord?n-Gonz?lez P, Gago-Pi?ero R, V?zquez-Sanabria I, P?rez-R?os N, Vil? LM. Factors Associated With Disease Damage in Puerto Ricans With Primary Sj?gren Syndrome. J Clin Rheumatol. 2020 Oct; 26(7S Suppl 2):S101-S105.
    View in: PubMed
    Score: 0.058
  6. V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
    View in: PubMed
    Score: 0.057
  7. Gago R, Vil? S, V?lez-Rivera J, Vil? LM. Severe systemic inflammatory response syndrome immediately after spinal surgery in a patient with axial gout. BMJ Case Rep. 2018 Jan 24; 2018.
    View in: PubMed
    Score: 0.049
  8. Arroyo-?vila M, Cab?n A, Garc?a-Rivera EJ, Irizarry-P?rez M, Torres H, Gorbea H, Vil? LM. Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection. Am J Trop Med Hyg. 2017 Apr; 96(4):916-921.
    View in: PubMed
    Score: 0.045
  9. V?zquez-Sanabria IL, Vil? LM. Sustained Improvement of Fibromyalgia Syndrome After Electroconvulsive Therapy for Intractable Depression. J Clin Rheumatol. 2016 Aug; 22(5):289-90.
    View in: PubMed
    Score: 0.044
  10. Fred-Jim?nez RM, Arroyo-?vila M, Mayor ?M, R?os G, Vil? LM. Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome. J Obes. 2016; 2016:1379289.
    View in: PubMed
    Score: 0.042
  11. Arroyo-?vila M, Vil? LM. Cardiac tamponade in a patient with mixed connective tissue disease. J Clin Rheumatol. 2015 Jan; 21(1):42-5.
    View in: PubMed
    Score: 0.039
  12. Arroyo-?vila M, Vil? LM. Limited systemic sclerosis initially presenting with mesenteric panniculitis. BMJ Case Rep. 2014 Oct 17; 2014.
    View in: PubMed
    Score: 0.039
  13. D?az-Correa LM, de Le?n-Tellado N, R?os G, Vil? LM. Granulomatosis with polyangiitis complicated with bronchopleural fistula. BMJ Case Rep. 2014 Sep 23; 2014.
    View in: PubMed
    Score: 0.038
  14. R?os G, Estrada M, Mayor AM, Vil? LM. Factors associated with tender point count in Puerto Ricans with fibromyalgia syndrome. P R Health Sci J. 2014 Sep; 33(3):112-6.
    View in: PubMed
    Score: 0.038
  15. Villafr?dez-D?az M, Santiago-Casas Y, Nieves-Plaza M, Morales M, Rodr?guez V, R?os G, Mart?nez D, Vil? LM. Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis. P R Health Sci J. 2014 Mar; 33(1):3-8.
    View in: PubMed
    Score: 0.037
  16. Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vil? LM. Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus. Clin Rheumatol. 2014 Jul; 33(7):995-1000.
    View in: PubMed
    Score: 0.037
  17. D?az-Correa LM, Ram?rez-Garc?a LM, Castro-Santana LE, Vil? LM. Osteoporosis knowledge in patients with a first fragility fracture in Puerto Rico. Bol Asoc Med P R. 2014; 106(1):6-10.
    View in: PubMed
    Score: 0.037
  18. Jim?nez-Encarnaci?n E, Vil? LM. Recurrent venous thrombosis in Ehlers-Danlos syndrome type III: an atypical manifestation. BMJ Case Rep. 2013 Jun 27; 2013.
    View in: PubMed
    Score: 0.035
  19. Santiago-Casas Y, Gonz?lez-Rivera T, Castro-Santana L, R?os G, Mart?nez D, Rodr?guez V, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico. Clin Rheumatol. 2013 Jun; 32(6):763-9.
    View in: PubMed
    Score: 0.034
  20. Nieves-Plaza M, Castro-Santana LE, Font YM, Mayor AM, Vil? LM. Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. J Clin Rheumatol. 2013 Jan; 19(1):1-6.
    View in: PubMed
    Score: 0.034
  21. Jim?nez-Encarnaci?n E, R?os G, Mu?oz-Mirabal A, Vil? LM. Euforia-induced acute hepatitis in a patient with scleroderma. BMJ Case Rep. 2012 Dec 19; 2012.
    View in: PubMed
    Score: 0.034
  22. L?pez-L?pez L, Rivera-Rodr?guez N, Vil? LM. Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep. 2012 Sep 12; 2012.
    View in: PubMed
    Score: 0.033
  23. Jim?nez-Encarnaci?n E, Garc?a-Pallas MV, Vil? LM. Severe leg ulcers in a multiple myeloma patient with cryoglobulinemic vasculitis. P R Health Sci J. 2012 Jun; 31(2):71.
    View in: PubMed
    Score: 0.033
  24. L?pez-L?pez L, Gonz?lez A, Vil? LM. Long-term membranous glomerulonephritis as the presenting manifestation of systemic lupus erythematosus in a patient with human immunodeficiency virus infection. Lupus. 2012 Jul; 21(8):900-4.
    View in: PubMed
    Score: 0.032
  25. Burgos PI, McGwin G, Pons-Estel GJ, Reveille JD, Alarc?n GS, Vil? LM. US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). Ann Rheum Dis. 2011 Feb; 70(2):393-4.
    View in: PubMed
    Score: 0.029
  26. Santiago-Casas Y, Gonz?lez-Rivera TC, Castro-Santana LE, R?os G, Mart?nez D, Rodr?guez VE, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethn Dis. 2010; 20(1 Suppl 1):S1-191-5.
    View in: PubMed
    Score: 0.028
  27. Burgos PI, Alarc?n GS, McGwin G, Crews KQ, Reveille JD, Vil? LM. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum. 2009 Sep 15; 61(9):1179-86.
    View in: PubMed
    Score: 0.027
  28. Negr?n AM, Molina MJ, Mayor AM, Rodr?guez VE, Vil? LM. Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus. 2008 Apr; 17(4):348-54.
    View in: PubMed
    Score: 0.025
  29. Molina MJ, Mayor AM, Franco AE, Morell CA, L?pez MA, Vil? LM. Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico. J Clin Rheumatol. 2007 Aug; 13(4):202-4.
    View in: PubMed
    Score: 0.023
  30. Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum. 2006 Oct 15; 55(5):799-806.
    View in: PubMed
    Score: 0.022
  31. Vil? LM, Molina MJ, Mayor AM, Cruz JJ, R?os-Olivares E, R?os Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol. 2007 May; 26(5):718-22.
    View in: PubMed
    Score: 0.022
  32. Vil? LM, Molina MJ, Mayor AM, Peredo RA, Santaella ML, Vil? S. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus. Lupus. 2006; 15(12):892-8.
    View in: PubMed
    Score: 0.021
  33. Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol. 2005 Nov; 32(11):2150-5.
    View in: PubMed
    Score: 0.021
  34. Vil? LM, Alarc?n GS, McGwin G, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford). 2004 Mar; 43(3):358-63.
    View in: PubMed
    Score: 0.018
  35. Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.
    View in: PubMed
    Score: 0.018
  36. Ugarte-Gil MF, Dubey J, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus. Arthritis Care Res (Hoboken). 2023 03; 75(3):585-589.
    View in: PubMed
    Score: 0.017
  37. Ugarte-Gil MF, Pons-Estel GJ, Harvey GB, Vil? LM, Griffin R, Alarc?n GS. Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort. Arthritis Care Res (Hoboken). 2021 10; 73(10):1451-1455.
    View in: PubMed
    Score: 0.016
  38. Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
    View in: PubMed
    Score: 0.015
  39. Vil? LM, Mayor AM, Silvestrini IE. Therapeutic response and long-term follow-up in a systemic lupus erythematosus patient presenting with Kikuchi's disease. Lupus. 2001; 10(2):126-8.
    View in: PubMed
    Score: 0.015
  40. Vil? LM, Mayor AM, Valent?n AH, Rodr?guez SI, Reyes ML, Acosta E, Vil? S. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J. 1999 Jun; 18(2):89-94.
    View in: PubMed
    Score: 0.013
  41. Alarc?n GS, Ugarte-Gil MF, Pons-Estel G, Vil? LM, Reveille JD, McGwin G. Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort. Lupus. 2019 Mar; 28(3):423-426.
    View in: PubMed
    Score: 0.013
  42. Vil? LM, Mayor AM, Valent?n AH, Garc?a-Soberal M, Vil? S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus. 1999; 8(4):279-86.
    View in: PubMed
    Score: 0.013
  43. Zuo Y, Willis R, Papalardo E, Petri M, Harris EN, Schleh A, DeCeulaer K, Smikle M, Vil? LM, Reveille JD, Alarc?n GS, Gonzalez EB. A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients. Lupus. 2017 May; 26(6):606-615.
    View in: PubMed
    Score: 0.011
  44. Ugarte-Gil MF, Pimentel-Quiroz VR, Vil? LM, Reveille JD, McGwin G, Alarc?n GS. Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort. Lupus. 2017 May; 26(6):650-655.
    View in: PubMed
    Score: 0.011
  45. Arroyo-?vila M, Santiago-Casas Y, McGwin G, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarc?n GS, Vil? LM, Brown EE. Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort. Clin Rheumatol. 2015 Jul; 34(7):1217-23.
    View in: PubMed
    Score: 0.010
  46. Zhao J, Giles BM, Taylor RL, Yette GA, Lough KM, Ng HL, Abraham LJ, Wu H, Kelly JA, Glenn SB, Adler AJ, Williams AH, Comeau ME, Ziegler JT, Marion M, Alarc?n-Riquelme ME, Alarc?n GS, Anaya JM, Bae SC, Kim D, Lee HS, Criswell LA, Freedman BI, Gilkeson GS, Guthridge JM, Jacob CO, James JA, Kamen DL, Merrill JT, Sivils KM, Niewold TB, Petri MA, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Vil? LM, Vyse TJ, Kaufman KM, Harley JB, Langefeld CD, Gaffney PM, Brown EE, Edberg JC, Kimberly RP, Ulgiati D, Tsao BP, Boackle SA. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis. 2016 Jan; 75(1):242-52.
    View in: PubMed
    Score: 0.010
  47. L?pez-L?pez L, Nieves-Plaza M, Castro Mdel R, Font YM, Torres-Ramos CA, Vil? LM, Ayala-Pe?a S. Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus. Lupus. 2014 Oct; 23(11):1133-41.
    View in: PubMed
    Score: 0.009
  48. Kaiser R, Taylor KE, Deng Y, Zhao J, Li Y, Nititham J, Chang M, Catanese J, Begovich AB, Brown EE, Edberg JC, McGwin G, Alarc?n GS, Ramsey-Goldman R, Reveille JD, Vila LM, Petri M, Kimberly RP, Feng X, Sun L, Shen N, Li W, Lu JX, Wakeland EK, Li QZ, Yang W, Lau YL, Liu FL, Chang DM, Yu CY, Song YW, Tsao BP, Criswell LA. Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians. Arthritis Rheum. 2013 Jan; 65(1):211-5.
    View in: PubMed
    Score: 0.009
  49. S?nchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, Garc?a-De La Torre I, Maradiaga-Cece?a MA, Cardiel MH, Esquivel-Valerio JA, Rodriguez-Amado J, Moctezuma JF, Miranda P, Perandones CE, Castel C, Laborde HA, Alba P, Musuruana JL, Goecke IA, Anaya JM, Kaufman KM, Adler A, Glenn SB, Brown EE, Alarc?n GS, Kimberly RP, Edberg JC, Vil? LM, Criswell LA, Gilkeson GS, Niewold TB, Mart?n J, Vyse TJ, Boackle SA, Ramsey-Goldman R, Scofield RH, Petri M, Merrill JT, Reveille JD, Tsao BP, Orozco L, Baca V, Moser KL, Gaffney PM, James JA, Harley JB, Tusi?-Luna T, Pons-Estel BA, Jacob CO, Alarc?n-Riquelme ME. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 2012 Nov; 64(11):3687-94.
    View in: PubMed
    Score: 0.008
  50. Kaiser R, Li Y, Chang M, Catanese J, Begovich AB, Brown EE, Edberg JC, McGwin G, Alarc?n GS, Ramsey-Goldman R, Reveille JD, Vil? LM, Petri MA, Kimberly RP, Taylor KE, Criswell LA. Genetic risk factors for thrombosis in systemic lupus erythematosus. J Rheumatol. 2012 Aug; 39(8):1603-10.
    View in: PubMed
    Score: 0.008
  51. Santiago-Casas Y, Vil? LM, McGwin G, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarc?n GS, Brown EE. Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012 May; 64(5):704-12.
    View in: PubMed
    Score: 0.008
  52. Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012 Jul; 21(8):830-5.
    View in: PubMed
    Score: 0.008
  53. Tan W, Sunahori K, Zhao J, Deng Y, Kaufman KM, Kelly JA, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Bae SC, Lee JH, Lee JS, Chang DM, Song YW, Yu CY, Kimberly RP, Edberg JC, Brown EE, Petri MA, Ramsey-Goldman R, Vil? LM, Reveille JD, Alarc?n-Riquelme ME, Harley JB, Boackle SA, Stevens AM, Scofield RH, Merrill JT, Freedman BI, Anaya JM, Criswell LA, Jacob CO, Vyse TJ, Niewold TB, Gaffney PM, Moser KL, Gilkeson GS, Kamen DL, James JA, Grossman JM, Hahn BH, Tsokos GC, Tsao BP, Alarc?n GS. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum. 2011 Sep; 63(9):2755-63.
    View in: PubMed
    Score: 0.008
  54. Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Gilkeson GS, Ziegler JT, Langefeld CD, Alarc?n GS, Edberg JC, Ramsey-Goldman R, Petri M, Brown EE, Kimberly RP, Reveille JD, Vil? LM, Merrill JT, Anaya JM, James JA, Pons-Estel BA, Martin J, Park SY, Bang SY, Bae SC, Moser KL, Vyse TJ, Criswell LA, Gaffney PM, Tsao BP, Jacob CO, Harley JB, Alarc?n-Riquelme ME, Sawalha AH. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011 Oct; 70(10):1752-7.
    View in: PubMed
    Score: 0.008
  55. Burgos PI, McGwin G, Reveille JD, Vil? LM, Brown EE, Alarcon GS. Is familial lupus different from sporadic lupus? Data from LUMINA (LXXIII), a multiethnic US cohort. Lupus. 2010 Oct; 19(11):1331-6.
    View in: PubMed
    Score: 0.007
  56. Freedman BI, Edberg JC, Comeau ME, Murea M, Bowden DW, Divers J, Alarc?n GS, Brown EE, McGwin G, Kopp JB, Winkler CA, Nelson GW, Illei G, Petri M, Ramsey-Goldman R, Reveille JD, Vil? LM, Langefeld CD, Kimberly RP. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol. 2010; 32(1):66-72.
    View in: PubMed
    Score: 0.007
  57. Burgos PI, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). Rheumatology (Oxford). 2010 Sep; 49(9):1720-5.
    View in: PubMed
    Score: 0.007
  58. Burgos PI, Vil? LM, Reveille JD, Alarc?n GS. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). Lupus. 2009 Dec; 18(14):1303-8.
    View in: PubMed
    Score: 0.007
  59. Bertoli AM, Vil? LM, Alarc?n GS, McGwin G, Edberg JC, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP. Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort. Lupus. 2009 Oct; 18(11):958-65.
    View in: PubMed
    Score: 0.007
  60. Gonz?lez LA, Pons-Estel GJ, Zhang J, Vil? LM, Reveille JD, Alarc?n GS. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort. Lupus. 2009 Aug; 18(9):822-30.
    View in: PubMed
    Score: 0.007
  61. Pons-Estel GJ, Gonz?lez LA, Zhang J, Burgos PI, Reveille JD, Vil? LM, Alarc?n GS. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology (Oxford). 2009 Jul; 48(7):817-22.
    View in: PubMed
    Score: 0.007
  62. Danila MI, Pons-Estel GJ, Zhang J, Vil? LM, Reveille JD, Alarc?n GS. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford). 2009 May; 48(5):542-5.
    View in: PubMed
    Score: 0.007
  63. Gonz?lez LA, Pons-Estel GJ, Zhang JS, McGwin G, Roseman J, Reveille JD, Vil? LM, Alarc?n GS. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus. 2009 Feb; 18(2):184-6.
    View in: PubMed
    Score: 0.007
  64. Sanchez ML, McGwin G, Dur?n S, Fern?ndez M, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1):67-71.
    View in: PubMed
    Score: 0.006
  65. Bertoli AM, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol. 2008 Dec; 35(12):2355-8.
    View in: PubMed
    Score: 0.006
  66. Fern?ndez M, McGwin G, Andrade R, Bastian HM, Fessler BJ, Reveille JD, Vil? LM, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort, LUMINA (XLIX): preliminary evaluation of the impact of statins on disease activity. J Clin Rheumatol. 2008 Jun; 14(3):178-80.
    View in: PubMed
    Score: 0.006
  67. Dur?n-Barrag?n S, McGwin G, Vil? LM, Reveille JD, Alarc?n GS. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort. Rheumatology (Oxford). 2008 Jul; 47(7):1093-6.
    View in: PubMed
    Score: 0.006
  68. Tucker LB, Uribe AG, Fern?ndez M, Vil? LM, McGwin G, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarc?n GS. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008 Apr; 17(4):314-22.
    View in: PubMed
    Score: 0.006
  69. Ramsey-Goldman R, Alarc?n GS, McGwin G, Petri M, Vil? LM, Edberg JC, Reveille JD, Kimberly RP. Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort. Lupus. 2008 Mar; 17(3):177-84.
    View in: PubMed
    Score: 0.006
  70. Apte M, McGwin G, Vil? LM, Kaslow RA, Alarc?n GS, Reveille JD. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. Rheumatology (Oxford). 2008 Mar; 47(3):362-7.
    View in: PubMed
    Score: 0.006
  71. Fern?ndez M, Calvo-Al?n J, Bertoli AM, Bastian HM, Fessler BJ, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. J Clin Rheumatol. 2007 Oct; 13(5):261-5.
    View in: PubMed
    Score: 0.006
  72. Andrade RM, Alarc?n GS, Gonz?lez LA, Fern?ndez M, Apte M, Vil? LM, McGwin G, Reveille JD. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis. 2008 Jun; 67(6):829-34.
    View in: PubMed
    Score: 0.006
  73. Bertoli AM, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus. Ann Rheum Dis. 2008 Apr; 67(4):500-4.
    View in: PubMed
    Score: 0.006
  74. Fern?ndez M, Alarc?n GS, McGwin G, Sanchez ML, Apte M, Vil? LM, Reveille JD. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. Arthritis Rheum. 2007 Aug 15; 57(6):986-92.
    View in: PubMed
    Score: 0.006
  75. Bertoli AM, Vil? LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology (Oxford). 2007 Sep; 46(9):1471-6.
    View in: PubMed
    Score: 0.006
  76. Fern?ndez M, Alarc?n GS, Calvo-Al?n J, Andrade R, McGwin G, Vil? LM, Reveille JD. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007 May 15; 57(4):576-84.
    View in: PubMed
    Score: 0.006
  77. Alarc?n GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Al?n J, Bastian HM, Vil? LM, Reveille JD. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007 Sep; 66(9):1168-72.
    View in: PubMed
    Score: 0.006
  78. Fern?ndez M, Alarc?n GS, Apte M, Andrade RM, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum. 2007 Feb; 56(2):614-21.
    View in: PubMed
    Score: 0.006
  79. Andrade RM, Alarc?n GS, Fern?ndez M, Apte M, Vil? LM, Reveille JD. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007 Feb; 56(2):622-30.
    View in: PubMed
    Score: 0.006
  80. Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus. 2007; 16(6):410-7.
    View in: PubMed
    Score: 0.006
  81. Bastian HM, Alarc?n GS, Roseman JM, McGwin G, Vil? LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford). 2007 Apr; 46(4):683-9.
    View in: PubMed
    Score: 0.006
  82. Alarc?n GS, McGwin G, Petri M, Ramsey-Goldman R, Fessler BJ, Vil? LM, Edberg JC, Reveille JD, Kimberly RP. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 2006 Oct; 3(10):e396.
    View in: PubMed
    Score: 0.006
  83. Bertoli AM, Fern?ndez M, Alarc?n GS, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis. 2007 Jan; 66(1):12-7.
    View in: PubMed
    Score: 0.005
  84. Bertoli AM, Alarc?n GS, Calvo-Al?n J, Fern?ndez M, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum. 2006 May; 54(5):1580-7.
    View in: PubMed
    Score: 0.005
  85. Fern?ndez M, Calvo-Al?n J, Alarc?n GS, Roseman JM, Bastian HM, Fessler BJ, McGwin G, Vil? LM, Sanchez ML, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005 Jun; 52(6):1655-64.
    View in: PubMed
    Score: 0.005
  86. Szalai AJ, Alarc?n GS, Calvo-Al?n J, Toloza SM, McCrory MA, Edberg JC, McGwin G, Bastian HM, Fessler BJ, Vil? LM, Kimberly RP, Reveille JD. Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology (Oxford). 2005 Jul; 44(7):864-8.
    View in: PubMed
    Score: 0.005
  87. Toloza SM, Uribe AG, McGwin G, Alarc?n GS, Fessler BJ, Bastian HM, Vil? LM, Wu R, Shoenfeld Y, Roseman JM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004 Dec; 50(12):3947-57.
    View in: PubMed
    Score: 0.005
  88. Uribe AG, Vil? LM, McGwin G, Sanchez ML, Reveille JD, Alarc?n GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004 Oct; 31(10):1934-40.
    View in: PubMed
    Score: 0.005
  89. Toloza SM, Roseman JM, Alarc?n GS, McGwin G, Uribe AG, Fessler BJ, Bastian HM, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum. 2004 Oct; 50(10):3177-86.
    View in: PubMed
    Score: 0.005
  90. Alarc?n GS, McGwin G, Roseman JM, Uribe A, Fessler BJ, Bastian HM, Friedman AW, Baethge B, Vil? LM, Reveille JD. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum. 2004 Aug 15; 51(4):609-15.
    View in: PubMed
    Score: 0.005
  91. Alarc?n GS, McGwin G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, Bastian HM, Baethge BA, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004 Jun 15; 51(3):465-74.
    View in: PubMed
    Score: 0.005
  92. Mart?nez A, Vil? LM, R?os-Olivares E. Predominance of CD4+ T cells and Th2 cytokines in the pericardial fluid of a dermatomyositis patient with cardiac tamponade. Clin Exp Rheumatol. 2004 Jan-Feb; 22(1):135.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support